International Journal of Drug Delivery Technology
Volume 15, Issue 2

Formulation and Evaluation of Multiparticulate Pellet Systems for Antidiabetic and Antihypertensive Drugs: Application of Extrusion–Spheronization and Solution Layering Techniques

Shishupal S Bodhankar*, Mohini Sihare

Department of Pharmaceutical Science, Oriental University Indore (M.P.), India

Received: 21st Apr, 2025; Revised: 29th May, 2025; Accepted: 8th Jun, 2025; Available Online: 25th Jun, 2025 

ABSTRACT

The present study focuses on the development and comprehensive evaluation of sustained and controlled release multiparticulate pellet formulations for three therapeutic agents: Tolbutamide, Saxagliptin, and Verapamil. The primary objective was to enhance drug release profiles and patient compliance using extrusion–spheronization and solution layering techniques. Tolbutamide and Verapamil were formulated into matrix-based sustained release pellets using hydrophilic polymers (HPMC) and plasticizers (MCC), while Saxagliptin pellets were prepared via solution layering on nonpareil seeds with optional Eudragit RS 100 coating for controlled release. Optimization of formulation parameters was performed using factorial design.All formulations exhibited excellent flow properties, narrow particle size distribution (500–850 µm), and satisfactory morphology with minimal friability (<1%). Drug content uniformity across all batches remained within pharmacopeial limits (RSD < 2%). In vitro drug release studies showed that Tolbutamide was released steadily (98.7% in 5 hours), Saxagliptin was released in a zero-order controlled way (98.1% in 5 hours), and Verapamil was released in a pH-sensitive way (92.5% in 6 hours). These results fit Higuchi, zero-order, and first-order kinetic models, respectively. These results show that pelletization methods can be used to customize the release kinetics of drugs with different physical and chemical properties and therapeutic goals. This shows that they are good for making strong oral controlled release dosage forms.

Keywords: Multiparticulate Pellet Systems, Antidiabetic, Antihypertensive,Pelletization

How to cite this article: Shishupal S. Bodhankar, Mohini Sihare. Formulation and Evaluation of Multiparticulate Pellet Systems for Antidiabetic and Antihypertensive Drugs: Application of Extrusion–Spheronization and Solution Layering Techniques. International Journal of Drug Delivery Technology. 2025;15(2):444-51. doi: 10.25258/ijddt.15.2.10

REFERENCES

  1. Banker GS, Rhodes CT. Modern pharmaceutics 4th ed. Revised and expanded published by Marcel Dekker. 2002;121:371-8.
  2. Dhobale G, Kanawade S, Hande R, Dhobale S, Tare H. Analytical Method Development by Using UV-Spectrophotometer for Estimation of Valsartan in Bulk. International Journal of Pharmaceutical Quality Assurance. 2024;15(2):854-60.
  3. Pandey R, Selvamurthy W. Design and in vitro characterization of novel pulsatile delivery system of biguanide antidiabetic drug. Journal of Pharmacy and Bioallied Sciences. 2020 Jul 1;12(3):356-68.
  4. Mishra S, Shah H, Patel A, Tripathi SM, Malviya R, Prajapati BG. Applications of bioengineered polymer in the field of nano-based drug delivery. ACS omega. 2023 Dec 18;9(1):81-96.
  5. Maboos M, Yousuf RI, Shoaib MH, Nasiri I, Hussain T, Ahmed HF, Iffat W. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets. Lipids in health and disease. 2018 Dec;17:1-7.
  6. Shanmugam S, Chakrahari R, Sundaramoorthy K, Ayyappan T, Vetrichelvan T. Formulation and evaluation of sustained release matrix tablets of Losartan potassium. International Journal of PharmTech Research. 2011 Jan;3(1):526-234.
  7. Shirwaikar AA, Jacob S, Grover V. Formulation and evaluation of sustained release tablets using an insoluble rosin matrix system. Indian J. Pharm. Sci. 2005;67(1):80-3.
  8. Mukherjee B, Mahanti B, Panda P, Mahapatra S. Preparation and evaluation of verapamil hydrochloride microcapsules. American journal of therapeutics. 2005 Sep 1;12(5):417-24.
  9. Modi SA, Gaikwad PD, Bankar VH, Pawar SP. Sustained release drug delivery system: a review. International Journal of Pharma Research and Development. 2011 Feb;2(12):147-60.
  10. Costa P, Lobo JM. Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences. 2001 May 1;13(2):123-33.
  11. Pund S, Nalawade S, Rajurkar V, Jayatpal S, Deshmukh N, Tare H. A brief review on recent advances in reverse phase HPLC. Multidisciplinary Reviews. 2024 Jan 18;7(4):2024072-.
  12. Gioumouxouzis CI, Karavasili C, Fatouros DG. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies. Drug discovery today. 2019 Feb 1;24(2):636-43.
  13. Kadam S, Bhalerao R, Pawar S, Tare H. Stability Indicating Force Degradation Study of Nintedanib in Bulk and Pharmaceutical Dosage Form. International Journal of Drug Delivery Technology. 2024;14(2):879-885.
  14. Shukla D, Chakraborty S, Singh S, Mishra B. Lipid-based oral multiparticulate formulations–advantages, technological advances and industrial applications. Expert opinion on drug delivery. 2011 Feb 1;8(2):207-24.
  15. Kim DW, Weon KY. Pharmaceutical application and development of fixed-dose combination: Dosage form review. Journal of Pharmaceutical Investigation. 2021 Sep;51:555-70.